Back to Janus Henderson Group Ltd.

LXEO
Showing 8 of 10 quarters

Position history for Janus Henderson Group Ltd.'s holdings in LEXEO THERAPEUTICS INC

Janus Henderson Group Ltd. holds 5M shares of LXEO (LEXEO THERAPEUTICS INC), worth $28.5M as of 2026-Q1. The position was decreased (-9.7% shares). LXEO represents 0.0% of Janus Henderson Group Ltd.'s portfolio.

Current Value

$28.5M

Current Shares

5M

Total Value Change

-$22.2M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
5M
-9.7%
$28.5M0.0%$7.07
0
2025-Q4
Decreased
5.5M
-9.8%
$54.7M0.0%$9.74
0
2025-Q3
Increased
6.1M
+65.7%
$40.5M0.0%$6.66
43
2025-Q2
Decreased
3.7M
-19.2%
$14.8M0.0%$4.12
0
2025-Q1
Increased
4.6M
+5.0%
$18.6M0.0%$4.10
30
2024-Q4
Increased
4.3M
+15.3%
$28.5M0.0%$6.54
33
2024-Q3
Increased
3.8M
+18.9%
$34M0.0%$9.11
34
2024-Q2
Increased
3.2M
+24.5%
$50.7M0.0%$16.04
36

Other major holders of LXEO: RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC, D1 Capital Partners L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used